Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Receivables (2021 - 2025)

Intelligent Bio Solutions has reported Receivables over the past 4 years, most recently at $961808.0 for Q2 2024.

  • For Q2 2024, Receivables rose 21.35% year-over-year to $961808.0; the TTM value through Jun 2024 reached $961808.0, up 21.35%, while the annual FY2024 figure was $955036.0, 20.49% up from the prior year.
  • Receivables for Q2 2024 was $961808.0 at Intelligent Bio Solutions, up from $764117.0 in the prior quarter.
  • Over five years, Receivables peaked at $2.9 million in Q1 2022 and troughed at $552001.0 in Q4 2023.
  • A 4-year average of $1.6 million and a median of $1.0 million in 2023 define the central range for Receivables.
  • Biggest five-year swings in Receivables: crashed 79.27% in 2023 and later rose 21.35% in 2024.
  • Year by year, Receivables stood at $2.8 million in 2021, then decreased by 5.83% to $2.7 million in 2022, then crashed by 79.27% to $552001.0 in 2023, then soared by 74.24% to $961808.0 in 2024.
  • Business Quant data shows Receivables for INBS at $961808.0 in Q2 2024, $764117.0 in Q1 2024, and $552001.0 in Q4 2023.